On Friday, April 23, 2021, the President signed into law:
S. 164, the “Advancing Education on Biosimilars Act of 2021,” which authorizes the Food and Drug Administration to educate consumers and health care providers on biologic products, including biosimilars;
S. 415, which clarifies the definition of a new chemical entity for the purposes of an application for approval by the Food and Drug Administration;
S. 422, the “Senate Shared Employee Act,” which allows Senators, Senators-elect, committees of the Senate, leadership offices, and other offices of the Senate to share employees; and
S. 578, the “Food Allergy Safety, Treatment, Education, and Research Act of 2021 or the FASTER Act of 2021,” which adds sesame to the list of major allergens for purposes of food labeling.